Lingfei Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lingfei Guo has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Changhu Liang
Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
29 shared publications - Chaofan Sui
Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Department of Radiology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong China
17 shared publications - Meng Li
Department of Psychiatry and Psychotherapy, Jena University Hospital, Germany
17 shared publications Nan Zhang
Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University
16 shared publications- Hongwei Wen
School of Medical Imaging, North Sichuan Medical College, Nanchong 637000, Sichuan, China
14 shared publications - Linfeng Yang
Department of Radiology Jinan Maternity and Child Care Hospital affiliated to Shandong First Medical University Jinan Shandong China
14 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1975285
Magnetic susceptibility source separation technology: a narrative review of principles, validation, and clinical translation
Quantitative susceptibility mapping (QSM) returns the net susceptibility of each voxel. When paramagnetic and diamagnetic materials coexist, their opposing contributions can cancel, and QSM cannot recover them separately. Magnetic susceptibility source separation (MSSS) adds a relaxation-sensitive measurement, usually R2′ or a calibrated estimate derived from R2*, to the signed local field. The combined data are used to estimate paramagnetic- and diamagnetic-associated components. In this narrative review, we examine the acquisition demands, physical assumptions, validation, and clinical use of the main MSSS methods. We consider R2′-based χ-separation, the GRE-only DECOMPOSE-QSM and R2*QSM methods, adaptive-parameter techniques, and deep-learning pipelines. Simulations and phantom studies support technical feasibility, and a smaller body of ex vivo and in vivo work provides biological and clinical evidence. These maps nevertheless remain model-dependent surrogates, not direct measurements of iron or myelin concentration. Interpretation is affected by susceptibility anisotropy, source geometry, diffusion, multicompartment water, errors in R2 estimation, and differences between scanners and protocols. Early longitudinal studies in multiple sclerosis (MS) have linked component changes to lesion repair. Evidence on paramagnetic rim lesions, however, still comes mainly from conventional phase or QSM imaging, and MSSS-specific clinical data are limited. Studies in Parkinson’s and Alzheimer’s disease are exploratory. Before routine clinical use, MSSS needs real-world validation, anisotropy-aware modeling, harmonized multicenter acquisition, and independent longitudinal testing.
- 12 November 2026
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 20, 1975285
Open AccessMagnetic susceptibility source separation technology: a narrative review of principles, validation, and clinical translation
Quantitative susceptibility mapping (QSM) returns the net susceptibility of each voxel. When paramagnetic and diamagnetic materials coexist, their opposing contributions can cancel, and QSM cannot recover them separately. Magnetic susceptibility source separation (MSSS) adds a relaxation-sensitive measurement, usually R2′ or a calibrated estimate derived from R2*, to the signed local field. The combined data are used to estimate paramagnetic- and diamagnetic-associated components. In this narrative review, we examine the acquisition demands, physical assumptions, validation, and clinical use of the main MSSS methods. We consider R2′-based χ-separation, the GRE-only DECOMPOSE-QSM and R2*QSM methods, adaptive-parameter techniques, and deep-learning pipelines. Simulations and phantom studies support technical feasibility, and a smaller body of ex vivo and in vivo work provides biological and clinical evidence. These maps nevertheless remain model-dependent surrogates, not direct measurements of iron or myelin concentration. Interpretation is affected by susceptibility anisotropy, source geometry, diffusion, multicompartment water, errors in R2 estimation, and differences between scanners and protocols. Early longitudinal studies in multiple sclerosis (MS) have linked component changes to lesion repair. Evidence on paramagnetic rim lesions, however, still comes mainly from conventional phase or QSM imaging, and MSSS-specific clinical data are limited. Studies in Parkinson’s and Alzheimer’s disease are exploratory. Before routine clinical use, MSSS needs real-world validation, anisotropy-aware modeling, harmonized multicenter acquisition, and independent longitudinal testing.
- 9 November 2026
- Published by Elsevier in Neuroscience
- Vol. 620, 158-167
Regional cortical thinning in cerebral small vessel disease: associations with disease burden and cognitive and motor impairment
- 9 November 2026
- Published by Elsevier in Neuroscience
- Vol. 620, 158-167
Regional cortical thinning in cerebral small vessel disease: associations with disease burden and cognitive and motor impairment
- Open Access
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1912049
Choroid plexus volume in metabolic syndrome: a cross-sectional neuroimaging study
Objectives: Our investigation aimed to explore the associations between choroid plexus (CP) volume and metabolic syndrome (MetS) components and cognitive-motor performance in a cross-sectional sample. Methods: A total of 211 participants (73 with MetS and 138 non-MetS controls) were included in this study. CP volume was automatically segmented from 3D T1-weighted images using a 3D nnU-Net. CP volume was normalized to estimated total intracranial volume (eTIV) and expressed as the CP/eTIV ratio. Multivariable linear regression analyses and Spearman correlation analyses were used to examine associations among the CP/eTIV ratio, MetS components and cognitive-motor domains. The Boruta algorithm was applied for exploratory feature selection, and receiver operating characteristic (ROC) analysis was used to evaluate the discriminative capacity of the selected variables for identifying participants with lower global cognitive-motor performance (lowest 25th percentile of global cognitive-motor composite). Results: Participants with MetS exhibited a higher CP/eTIV ratio than non-MetS controls, and higher CP/eTIV was independently associated with lower high-density lipoprotein cholesterol (HDL-C) levels ( FDR q = 0.024) after full adjustment and FDR correction. In unadjusted analyses, the CP/eTIV ratio was correlated with multiple cognitive-motor domains. However, these associations were no longer statistically significant after adjustment for confounders. Boruta analysis identified CP/eTIV, white matter hyperintensity (WMH) volume/eTIV, and BMI as key variables, and the combined model yielded an AUC of 0.787 (95% CI: 0.718 to 0.854) for discriminating participants with lower global cognitive-motor composite. DeLong's test showed that the combined model did not significantly outperform CP/eTIV alone (0.742 vs. 0.787; FDR q = 0.084) or the model of WMH/eTIV and BMI (0.729 vs. 0.787; FDR q = 0.084). Conclusion: A higher CP/eTIV ratio was associated with MetS and lower HDL-C levels, but was not independently associated with cognitive-motor performance after multivariable adjustment. CP structural variation may represent an imaging correlate of metabolic disturbance, and its relevance to cognitive vulnerability requires prospective validation.
- 16 October 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1912049
Open AccessChoroid plexus volume in metabolic syndrome: a cross-sectional neuroimaging study
Objectives: Our investigation aimed to explore the associations between choroid plexus (CP) volume and metabolic syndrome (MetS) components and cognitive-motor performance in a cross-sectional sample. Methods: A total of 211 participants (73 with MetS and 138 non-MetS controls) were included in this study. CP volume was automatically segmented from 3D T1-weighted images using a 3D nnU-Net. CP volume was normalized to estimated total intracranial volume (eTIV) and expressed as the CP/eTIV ratio. Multivariable linear regression analyses and Spearman correlation analyses were used to examine associations among the CP/eTIV ratio, MetS components and cognitive-motor domains. The Boruta algorithm was applied for exploratory feature selection, and receiver operating characteristic (ROC) analysis was used to evaluate the discriminative capacity of the selected variables for identifying participants with lower global cognitive-motor performance (lowest 25th percentile of global cognitive-motor composite). Results: Participants with MetS exhibited a higher CP/eTIV ratio than non-MetS controls, and higher CP/eTIV was independently associated with lower high-density lipoprotein cholesterol (HDL-C) levels ( FDR q = 0.024) after full adjustment and FDR correction. In unadjusted analyses, the CP/eTIV ratio was correlated with multiple cognitive-motor domains. However, these associations were no longer statistically significant after adjustment for confounders. Boruta analysis identified CP/eTIV, white matter hyperintensity (WMH) volume/eTIV, and BMI as key variables, and the combined model yielded an AUC of 0.787 (95% CI: 0.718 to 0.854) for discriminating participants with lower global cognitive-motor composite. DeLong's test showed that the combined model did not significantly outperform CP/eTIV alone (0.742 vs. 0.787; FDR q = 0.084) or the model of WMH/eTIV and BMI (0.729 vs. 0.787; FDR q = 0.084). Conclusion: A higher CP/eTIV ratio was associated with MetS and lower HDL-C levels, but was not independently associated with cognitive-motor performance after multivariable adjustment. CP structural variation may represent an imaging correlate of metabolic disturbance, and its relevance to cognitive vulnerability requires prospective validation.
- 28 August 2026
- Published by SAGE Publications in International Journal of Stroke
MRI-derived oxygen extraction fraction is associated with cognitive impairment in cerebral small vessel disease
Background: Conventional MRI markers of cerebral small vessel disease (CSVD) capture accumulated structural injury but may not fully reflect ongoing physiological dysfunction associated with cognitive impairment. Aims: We investigated whether MRI-derived oxygen extraction fraction (OEF), a non-invasive marker of cerebral oxygen extraction, is associated with cognitive impairment in CSVD beyond conventional structural MRI burden. Methods: In this hospital-based observational study, 448 adults with CSVD underwent 3T multiecho gradient-echo MRI for whole-brain OEF mapping using a quantitative susceptibility mapping/quantitative blood oxygen level-dependent framework. Participants were classified as having mild cognitive impairment (MCI) or no MCI by a blinded clinical consensus panel. Whole-brain voxelwise analyses compared OEF between groups and examined associations with the composite cognitive score, Fazekas score, and total CSVD score; post hoc ROI-based analyses examined associations with conventional CSVD burden markers and a composite cognitive score. In an exploratory longitudinal subset of 82 participants, we assessed whether baseline OEF or within-subject OEF change was associated with cognitive change. Results: Participants with CSVD-MCI showed higher OEF in distributed cortical–subcortical regions than cognitively preserved participants after adjustment for demographic, vascular, and conventional CSVD burden variables. The largest cross-sectional cluster showed higher OEF in the CSVD-MCI group than in the CSVD-no-MCI group (0.342±0.045 vs. 0.294±0.027). Complementary whole-brain analyses and post hoc analyses of the largest group-difference cluster showed that higher OEF was associated with lower composite cognitive scores after covariate adjustment, whereas no associations with Fazekas score or total CSVD score were identified. In the longitudinal subset, baseline OEF was not associated with follow-up composite cognitive score or cognitive change, whereas greater within-subject OEF increase was associated with greater cognitive decline (standardised β=-0.229, p=0.030). Conclusions: MRI-derived OEF was associated with cognitive impairment in CSVD independently of conventional structural MRI burden. These findings suggest that OEF may provide complementary physiological information for characterising cognitive vulnerability in CSVD. Larger multicentre longitudinal studies incorporating quantitative perfusion imaging and validated amyloid and tau biomarkers are warranted.
- 28 August 2026
- Published by SAGE Publications in International Journal of Stroke
MRI-derived oxygen extraction fraction is associated with cognitive impairment in cerebral small vessel disease
Background: Conventional MRI markers of cerebral small vessel disease (CSVD) capture accumulated structural injury but may not fully reflect ongoing physiological dysfunction associated with cognitive impairment. Aims: We investigated whether MRI-derived oxygen extraction fraction (OEF), a non-invasive marker of cerebral oxygen extraction, is associated with cognitive impairment in CSVD beyond conventional structural MRI burden. Methods: In this hospital-based observational study, 448 adults with CSVD underwent 3T multiecho gradient-echo MRI for whole-brain OEF mapping using a quantitative susceptibility mapping/quantitative blood oxygen level-dependent framework. Participants were classified as having mild cognitive impairment (MCI) or no MCI by a blinded clinical consensus panel. Whole-brain voxelwise analyses compared OEF between groups and examined associations with the composite cognitive score, Fazekas score, and total CSVD score; post hoc ROI-based analyses examined associations with conventional CSVD burden markers and a composite cognitive score. In an exploratory longitudinal subset of 82 participants, we assessed whether baseline OEF or within-subject OEF change was associated with cognitive change. Results: Participants with CSVD-MCI showed higher OEF in distributed cortical–subcortical regions than cognitively preserved participants after adjustment for demographic, vascular, and conventional CSVD burden variables. The largest cross-sectional cluster showed higher OEF in the CSVD-MCI group than in the CSVD-no-MCI group (0.342±0.045 vs. 0.294±0.027). Complementary whole-brain analyses and post hoc analyses of the largest group-difference cluster showed that higher OEF was associated with lower composite cognitive scores after covariate adjustment, whereas no associations with Fazekas score or total CSVD score were identified. In the longitudinal subset, baseline OEF was not associated with follow-up composite cognitive score or cognitive change, whereas greater within-subject OEF increase was associated with greater cognitive decline (standardised β=-0.229, p=0.030). Conclusions: MRI-derived OEF was associated with cognitive impairment in CSVD independently of conventional structural MRI burden. These findings suggest that OEF may provide complementary physiological information for characterising cognitive vulnerability in CSVD. Larger multicentre longitudinal studies incorporating quantitative perfusion imaging and validated amyloid and tau biomarkers are warranted.
- 11 August 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
MRI Tract‐Based Quantitative Susceptibility Mapping of Limbic White Matter Alterations in Preeclampsia
Background: Preeclampsia is associated with long‐term cerebrovascular and cognitive risk, but tract‐level white matter (WM) involvement remains incompletely characterized. Purpose: To investigate whether preeclampsia is associated with tract‐level WM susceptibility alterations on quantitative susceptibility mapping (QSM) and whether these alterations are related to circulating hypoxia‐and brain injury‐associated proteins. Study Type: Prospective cohort study with exploratory postpartum follow‐up in a small subset. Population: 350 women (152 with preeclampsia, 73 pregnant healthy controls, and 125 nonpregnant healthy controls). Field Strength/Sequence: 1.5‐T MRI; multiecho gradient‐echo sequence for QSM, and 3D T1‐weighted turbo field echo, T2‐weighted turbo spin echo, T2‐weighted fluid‐attenuated inversion recovery imaging, and diffusion‐weighted echo‐planar imaging. Assessment: Quantitative susceptibility maps were reconstructed using MEDI+0. Mean susceptibility was extracted from 42 XTRACT‐defined WM tracts. Plasma hypoxia‐inducible factor‐1α, amyloid‐β1–42, total tau, and phosphorylated tau181 were measured using enzyme‐linked immunosorbent assays. Follow up MRI was performed after 1–3 years in 32 women with preeclampsia. Statistical Tests: Group differences were assessed using analysis of variance with Tukey post hoc testing and false discovery rate correction. Multivariable regression, partial Spearman correlation, and exploratory cross‐lagged panel modeling were performed. Results: Significant group differences in susceptibility were concentrated in limbic pathways, including the bilateral anterior thalamic radiations, right dorsal and perigenual cingulum, bilateral temporal cingulum, and bilateral fornix (FDR‐adjusted p < 0.05). Compared with pregnant healthy controls, women with preeclampsia had higher susceptibility in the bilateral temporal cingulum (left: 15.75 ± 13.37 vs. 9.95 ± 11.16 ppb, p < 0.05; right: 14.86 ± 14.39 vs. 8.48 ± 11.18 ppb, p < 0.05) and left fornix (5.07 ± 10.12 vs. 1.14 ± 6.65 ppb, p < 0.05). These associations persisted in pregnancy‐restricted models after extended adjustment ( β = 0.246–0.386; p < 0.05). Higher susceptibility correlated weakly with HIF‐1α and total tau ( ρ ≈0.22–0.27). The exploratory follow‐up analyses of 32 women with preeclampsia suggested that baseline biomarker levels were associated with later limbic tract susceptibility. Data Conclusion: Tract‐based QSM demonstrated preeclampsia‐associated limbic WM susceptibility alterations, mainly involving the temporal cingulum and left fornix compared with pregnant healthy controls. Exploratory postpartum findings require confirmation in larger longitudinal cohorts. Level of Evidence: 2. Technical Efficacy: Stage 2.
- 11 August 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
MRI Tract‐Based Quantitative Susceptibility Mapping of Limbic White Matter Alterations in Preeclampsia
Background: Preeclampsia is associated with long‐term cerebrovascular and cognitive risk, but tract‐level white matter (WM) involvement remains incompletely characterized. Purpose: To investigate whether preeclampsia is associated with tract‐level WM susceptibility alterations on quantitative susceptibility mapping (QSM) and whether these alterations are related to circulating hypoxia‐and brain injury‐associated proteins. Study Type: Prospective cohort study with exploratory postpartum follow‐up in a small subset. Population: 350 women (152 with preeclampsia, 73 pregnant healthy controls, and 125 nonpregnant healthy controls). Field Strength/Sequence: 1.5‐T MRI; multiecho gradient‐echo sequence for QSM, and 3D T1‐weighted turbo field echo, T2‐weighted turbo spin echo, T2‐weighted fluid‐attenuated inversion recovery imaging, and diffusion‐weighted echo‐planar imaging. Assessment: Quantitative susceptibility maps were reconstructed using MEDI+0. Mean susceptibility was extracted from 42 XTRACT‐defined WM tracts. Plasma hypoxia‐inducible factor‐1α, amyloid‐β1–42, total tau, and phosphorylated tau181 were measured using enzyme‐linked immunosorbent assays. Follow up MRI was performed after 1–3 years in 32 women with preeclampsia. Statistical Tests: Group differences were assessed using analysis of variance with Tukey post hoc testing and false discovery rate correction. Multivariable regression, partial Spearman correlation, and exploratory cross‐lagged panel modeling were performed. Results: Significant group differences in susceptibility were concentrated in limbic pathways, including the bilateral anterior thalamic radiations, right dorsal and perigenual cingulum, bilateral temporal cingulum, and bilateral fornix (FDR‐adjusted p < 0.05). Compared with pregnant healthy controls, women with preeclampsia had higher susceptibility in the bilateral temporal cingulum (left: 15.75 ± 13.37 vs. 9.95 ± 11.16 ppb, p < 0.05; right: 14.86 ± 14.39 vs. 8.48 ± 11.18 ppb, p < 0.05) and left fornix (5.07 ± 10.12 vs. 1.14 ± 6.65 ppb, p < 0.05). These associations persisted in pregnancy‐restricted models after extended adjustment ( β = 0.246–0.386; p < 0.05). Higher susceptibility correlated weakly with HIF‐1α and total tau ( ρ ≈0.22–0.27). The exploratory follow‐up analyses of 32 women with preeclampsia suggested that baseline biomarker levels were associated with later limbic tract susceptibility. Data Conclusion: Tract‐based QSM demonstrated preeclampsia‐associated limbic WM susceptibility alterations, mainly involving the temporal cingulum and left fornix compared with pregnant healthy controls. Exploratory postpartum findings require confirmation in larger longitudinal cohorts. Level of Evidence: 2. Technical Efficacy: Stage 2.
- Open Access
- 2 July 2026
- Published by Wolters Kluwer Health in Hypertension
Brain Iron in Nucleus Accumbens and Cognitive Function in Preeclampsia
BACKGROUND: Preeclampsia is associated with long-term cognitive dysfunction, potentially linked to cerebral iron deposition. This study investigated striatal iron alterations using quantitative susceptibility mapping and their relationship with cognitive function in patients with preeclampsia. METHODS: This cross-sectional study enrolled 321 participants, including nonpregnant and pregnant healthy controls, and patients with preeclampsia. Participants underwent the Montreal Cognitive Assessment, Trail Making Test, and 1.5 T brain magnetic resonance imaging. Striatal iron content was quantified using quantitative susceptibility mapping reconstructed with a morphology-enabled dipole inversion algorithm. RESULTS: Preeclampsia patients showed poorer executive function (Trail Making Test part [A+B]: partial η 2 =0.170; part B: partial η 2 =0.100) and elevated nucleus accumbens magnetic susceptibility (all P β =0.744, P β =0.846, P =0.011) were independently associated with iron levels. In addition, significant interactions between nucleus accumbens susceptibility values and preeclampsia status were observed for log-transformed Trail Making Test completion times (part [A+B]: interaction β =0.388, P =0.006; part B: interaction β =0.424, P =0.003), indicating that elevated iron specifically exacerbates executive vulnerability in preeclampsia. CONCLUSIONS: Nucleus accumbens iron level is elevated in preeclampsia and correlates with executive performance. Although the cross-sectional design limits causal conclusions, these findings highlight nucleus accumbens iron deposition as a key pathological feature underlying preeclampsia-related cerebral involvement.
- 2 July 2026
- Published by Wolters Kluwer Health in Hypertension
Open AccessBrain Iron in Nucleus Accumbens and Cognitive Function in Preeclampsia
BACKGROUND: Preeclampsia is associated with long-term cognitive dysfunction, potentially linked to cerebral iron deposition. This study investigated striatal iron alterations using quantitative susceptibility mapping and their relationship with cognitive function in patients with preeclampsia. METHODS: This cross-sectional study enrolled 321 participants, including nonpregnant and pregnant healthy controls, and patients with preeclampsia. Participants underwent the Montreal Cognitive Assessment, Trail Making Test, and 1.5 T brain magnetic resonance imaging. Striatal iron content was quantified using quantitative susceptibility mapping reconstructed with a morphology-enabled dipole inversion algorithm. RESULTS: Preeclampsia patients showed poorer executive function (Trail Making Test part [A+B]: partial η 2 =0.170; part B: partial η 2 =0.100) and elevated nucleus accumbens magnetic susceptibility (all P β =0.744, P β =0.846, P =0.011) were independently associated with iron levels. In addition, significant interactions between nucleus accumbens susceptibility values and preeclampsia status were observed for log-transformed Trail Making Test completion times (part [A+B]: interaction β =0.388, P =0.006; part B: interaction β =0.424, P =0.003), indicating that elevated iron specifically exacerbates executive vulnerability in preeclampsia. CONCLUSIONS: Nucleus accumbens iron level is elevated in preeclampsia and correlates with executive performance. Although the cross-sectional design limits causal conclusions, these findings highlight nucleus accumbens iron deposition as a key pathological feature underlying preeclampsia-related cerebral involvement.
- 13 April 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (10) , 1-12
Anteroposterior diameter of the pancreas in the diagnosis of autoimmune pancreatitis and acute pancreatitis on MRI
Objective This study aimed to quantitatively analyze the anteroposterior diameter of pancreas (ADpancreas) based on magnetic resonance imaging (MRI) data, and to evaluate their clinical value in diagnosing autoimmune pancreatitis (AIP) and differentiating it from acute pancreatitis (AP). Materials and methods MRI data from 32 patients with clinically confirmed diffuse AIP-1 were retrospectively analyzed. Thirty patients with AP and 32 individuals with normal pancreases were included as control groups. The anteroposterior diameters of the pancreatic head (ADhead), body (ADbody), and tail (ADtail), along with pancreatic volume and the transverse diameter of the first lumbar vertebral body (TDL1), were measured and compared across groups. Diagnostic performance was analyzed using receiver operating characteristic (ROC) curves. Results ADhead, ADbody, ADtail, and their ratios to TDL1 were significantly higher in the AIP group compared to the normal pancreas group (P < 0.05). ADbody, ADtail, and their ratios to TDL1 were also significantly higher in the AIP group than in the AP group (P < 0.05). No statistically significant difference was observed in pancreatic volume between the AIP and AP groups (P > 0.05). The area under the ROC curve (AUC) for ADhead, ADbody, ADtail, and their ratios to TDL1 in diagnosing AIP were 0.804, 0.773, 0.818, 0.786, 0.727, and 0.810, respectively. In the differential diagnosis of AIP and AP, the AUCs for ADhead, ADbody and ADtail and their ratios to TDL1 were 0.597, 0.708, 0.704, 0.545, 0.673, and 0.667, respectively. A logistic regression model incorporating ADhead, ADbody, and ADtail yielded an AUC of 0.732, which was significantly higher than that of pancreatic volume alone. Conclusion ADbodyand ADtail are valuable and practical adjunctive indicators for differentiating AIP from AP. The combination of ADhead, ADbody, and ADtail demonstrates higher diagnostic efficiency than pancreatic volume alone. These quantitative measurements are best used as supportive findings rather than standalone diagnostic criteria.
- 13 April 2026
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (10) , 1-12
Anteroposterior diameter of the pancreas in the diagnosis of autoimmune pancreatitis and acute pancreatitis on MRI
Objective This study aimed to quantitatively analyze the anteroposterior diameter of pancreas (ADpancreas) based on magnetic resonance imaging (MRI) data, and to evaluate their clinical value in diagnosing autoimmune pancreatitis (AIP) and differentiating it from acute pancreatitis (AP). Materials and methods MRI data from 32 patients with clinically confirmed diffuse AIP-1 were retrospectively analyzed. Thirty patients with AP and 32 individuals with normal pancreases were included as control groups. The anteroposterior diameters of the pancreatic head (ADhead), body (ADbody), and tail (ADtail), along with pancreatic volume and the transverse diameter of the first lumbar vertebral body (TDL1), were measured and compared across groups. Diagnostic performance was analyzed using receiver operating characteristic (ROC) curves. Results ADhead, ADbody, ADtail, and their ratios to TDL1 were significantly higher in the AIP group compared to the normal pancreas group (P < 0.05). ADbody, ADtail, and their ratios to TDL1 were also significantly higher in the AIP group than in the AP group (P < 0.05). No statistically significant difference was observed in pancreatic volume between the AIP and AP groups (P > 0.05). The area under the ROC curve (AUC) for ADhead, ADbody, ADtail, and their ratios to TDL1 in diagnosing AIP were 0.804, 0.773, 0.818, 0.786, 0.727, and 0.810, respectively. In the differential diagnosis of AIP and AP, the AUCs for ADhead, ADbody and ADtail and their ratios to TDL1 were 0.597, 0.708, 0.704, 0.545, 0.673, and 0.667, respectively. A logistic regression model incorporating ADhead, ADbody, and ADtail yielded an AUC of 0.732, which was significantly higher than that of pancreatic volume alone. Conclusion ADbodyand ADtail are valuable and practical adjunctive indicators for differentiating AIP from AP. The combination of ADhead, ADbody, and ADtail demonstrates higher diagnostic efficiency than pancreatic volume alone. These quantitative measurements are best used as supportive findings rather than standalone diagnostic criteria.
- 21 March 2026
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (6) , 1006-1015
Deep learning-driven MRI segmentation of choroid plexus volume: a novel biomarker for cognitive impairment in type 2 diabetes mellitus
- 21 March 2026
- Published by Springer Nature in Japanese Journal of Radiology
- Vol. 44 (6) , 1006-1015
Deep learning-driven MRI segmentation of choroid plexus volume: a novel biomarker for cognitive impairment in type 2 diabetes mellitus
- Open Access
- 9 January 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (3) , 100475
Preeclampsia as a reversible risk factor for Alzheimer’s disease: A prospective MRI study on morphological changes of the cerebral cortex and impairment of cognitive functions
- 9 January 2026
- Published by Elsevier in The Journal Of Prevention of Alzheimer's Disease
- Vol. 13 (3) , 100475
Open AccessPreeclampsia as a reversible risk factor for Alzheimer’s disease: A prospective MRI study on morphological changes of the cerebral cortex and impairment of cognitive functions
- Open Access
- 8 January 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (1) , e71080
Associations between metabolic syndrome and regional brain iron depositions and cognitive function in middle‐aged and older adults: A two multinational cohort study
INTRODUCTION: The alterations of regional brain iron in patients with metabolic syndrome (Mets) and its relationship with cognitive function remain unclear. METHODS: These analyses utilized data from two prospective cohorts, from the UK Biobank (UKB) (21,346 participants) and from Jinan, China (224 participants). We capitalized brain iron in the striatum and thalamus of UKB. Then voxel‐based analysis of quantitative susceptibility mapping (QSM) was used to detect regional susceptibility value alteration in our cohort and their relationship with cognitive function was assessed using linear regression. RESULTS: Mets patients exhibited iron deposition in the striatum and thalamus, which was mainly associated with hyperglycemia and elevated triglycerides among the risk factors in UKB. Mets patients exhibited iron deposition in the right caudate nucleus, which was associated with cognitive decline in the Jinan cohort. DISCUSSION: Regional brain iron deposition might serve as a neuroimaging biomarker of Mets severity and a potential mechanism for cognitive decline. Highlights: Iron deposition in deep gray matter nuclei was found in patients with metabolic syndrome (Mets) in both UK Biobank (UKB) and Jinan cohort. Iron deposition in the deep gray matter nuclei of Mets in UKB was mainly related to hyperglycemia and elevated triglycerides among metabolic risk factors. The UKB longitudinal study found that the susceptibility values of the caudate nucleus and putamen of Mets patients increased significantly with age compared to healthy controls. Patients with Mets exhibited poorer cognitive function, which was closely associated with iron deposition in the right caudate nucleus in the Jinan cohort. The association between iron deposition and cognition was more concentrated in the elderly, smokers and drinkers, and those with low years of education.
- 8 January 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (1) , e71080
Open AccessAssociations between metabolic syndrome and regional brain iron depositions and cognitive function in middle‐aged and older adults: A two multinational cohort study
INTRODUCTION: The alterations of regional brain iron in patients with metabolic syndrome (Mets) and its relationship with cognitive function remain unclear. METHODS: These analyses utilized data from two prospective cohorts, from the UK Biobank (UKB) (21,346 participants) and from Jinan, China (224 participants). We capitalized brain iron in the striatum and thalamus of UKB. Then voxel‐based analysis of quantitative susceptibility mapping (QSM) was used to detect regional susceptibility value alteration in our cohort and their relationship with cognitive function was assessed using linear regression. RESULTS: Mets patients exhibited iron deposition in the striatum and thalamus, which was mainly associated with hyperglycemia and elevated triglycerides among the risk factors in UKB. Mets patients exhibited iron deposition in the right caudate nucleus, which was associated with cognitive decline in the Jinan cohort. DISCUSSION: Regional brain iron deposition might serve as a neuroimaging biomarker of Mets severity and a potential mechanism for cognitive decline. Highlights: Iron deposition in deep gray matter nuclei was found in patients with metabolic syndrome (Mets) in both UK Biobank (UKB) and Jinan cohort. Iron deposition in the deep gray matter nuclei of Mets in UKB was mainly related to hyperglycemia and elevated triglycerides among metabolic risk factors. The UKB longitudinal study found that the susceptibility values of the caudate nucleus and putamen of Mets patients increased significantly with age compared to healthy controls. Patients with Mets exhibited poorer cognitive function, which was closely associated with iron deposition in the right caudate nucleus in the Jinan cohort. The association between iron deposition and cognition was more concentrated in the elderly, smokers and drinkers, and those with low years of education.